Fund Holdings — STEMPOINT CAPITAL LP

Total Portfolio Value:
$333.43M
Total Bought:
$111.62M
Total Sold:
$126.02M
Net Transaction:
-$14.40M
Notable People:
Michelle Avra Ross
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Syndax Pharmaceuticals, Inc.(SNDX)1,412,1761,731,191+319,015$28.99M$33.33M9.99%+$4.33M
Roivant Sciences Ltd.SHS(ROIV)2,712,7412,769,819+57,078$28.67M$31.96M9.59%+$3.29M
Merus N V288,668421,222+132,554$17.08M$21.04M6.31%+$3.96M
Immunovant, Inc.(IMVT)1,011,879671,001-340,878$26.71M$19.13M5.74%-$7.58M
Arcutis Biotherapeutics, Inc.(ARQT)965,3921,778,318+812,926$8.98M$16.54M4.96%+$7.56M
Amicus Therapeutics Inc
COM
1,495,0471,481,809-13,238$14.83M$15.83M4.75%+$994.9K
Bristol-Myers Squibb Company(BMY)0275,303+275,303$0$14.24M4.27%+$14.24M
Applied Therapeutics Inc2,211,3201,554,586-656,734$10.33M$13.21M3.96%+$2.89M
Crinetics Pharmaceuticals In551,095213,815-337,280$24.68M$10.93M3.28%-$13.76M
Biohaven Ltd.(BHVN)233,255216,440-16,815$8.10M$10.82M3.24%+$2.72M
Praxis Precision Medicines, Inc.(PRAX)29,259174,034+144,775$1.21M$10.01M3.00%+$8.80M
Autolus Therapeutics plcADS(AUTL)2,662,7322,616,602-46,130$9.27M$9.50M2.85%+$232.0K
Incyte Corporation(INCY)0129,490+129,490$0$8.56M2.57%+$8.56M
Denali Therapeutics Inc.(DNLI)251,010282,050+31,040$5.83M$8.22M2.46%+$2.39M
Day One Biopharmaceuticals I
COM
0506,978+506,978$0$7.06M2.12%+$7.06M
Acelyrin Inc01,317,854+1,317,854$0$6.50M1.95%+$6.50M
Soleno Therapeutics Inc0123,177+123,177$0$6.22M1.87%+$6.22M
Cabaletta Bio, Inc.(CABA)1,178,1051,278,444+100,339$8.81M$6.03M1.81%-$2.78M
Immatics N.V.SHS(IMTX)502,207449,735-52,472$5.84M$5.13M1.54%-$704.2K
Keros Therapeutics, Inc.(KROS)086,930+86,930$0$5.05M1.51%+$5.05M
Arcellx Inc
COMMON STOCK
280,70960,076-220,633$15.49M$5.02M1.50%-$10.48M
Vistagen Therapeutics, Inc.(VTGN)1,848,5821,846,792-1,790$5.85M$4.90M1.47%-$947.6K
Nurix Therapeutics, Inc.(NRIX)203,273203,015-258$4.24M$4.56M1.37%+$319.4K
TScan Therapeutics, Inc.(TCRX)845,069860,951+15,882$4.94M$4.29M1.29%-$656.1K
Zura Bio LimitedCL A(ZURA)01,044,168+1,044,168$0$4.24M1.27%+$4.24M
IDEAYA Biosciences, Inc.(IDYA)101,787132,703+30,916$3.57M$4.20M1.26%+$630.3K
Terns Pharmaceuticals Inc0449,321+449,321$0$3.75M1.12%+$3.75M
Perspective Therapeutics, Inc.(CATX)343,810238,084-105,726$3.43M$3.18M0.95%-$249.4K
Pyxis Oncology, Inc.(PYXS)1,202,675850,210-352,465$3.98M$3.12M0.94%-$860.6K
Neurogene Inc.(NGNE)78,60173,299-5,302$2.86M$3.08M0.92%+$215.3K
UroGen Pharma Ltd.(URGN)0241,984+241,984$0$3.07M0.92%+$3.07M
Vigil Neuroscience Inc744,412743,719-693$2.98M$2.53M0.76%-$449.0K
Wave Life Sciences, Inc.SHS(WVE)0300,000+300,000$0$2.46M0.74%+$2.46M
BridgeBio Pharma, Inc.(BBIO)094,885+94,885$0$2.42M0.72%+$2.42M
Janux Therapeutics, Inc.(JANX)92,94949,415-43,534$3.89M$2.24M0.67%-$1.65M
Surrozen, Inc.(SRZN)143,510182,918+39,408$1.57M$2.19M0.66%+$619.9K
Rhythm Pharmaceuticals, Inc.(RYTM)041,268+41,268$0$2.16M0.65%+$2.16M
Helix Acquisition Corp IiCL A200,000200,0000$2.04M$2.09M0.63%+$46.0K
Sarepta Therapeutics, Inc.(SRPT)015,014+15,014$0$1.88M0.56%+$1.88M
Protara Therapeutics, Inc.(TARA)984,113942,857-41,256$2.05M$1.73M0.52%-$321.5K
Perceptive Cap Solutions CorCL A
CL A ORD SHS
150,000150,0000$1.51M$1.50M0.45%-$6.0K
Tourmaline Bio Inc055,523+55,523$0$1.43M0.43%+$1.43M
Capricor Therapeutics, Inc.(CAPR)093,638+93,638$0$1.42M0.43%+$1.42M
Alkermes plcSHS(ALKS)048,918+48,918$0$1.37M0.41%+$1.37M
Centessa Pharmaceuticals PlcADS083,662+83,662$0$1.34M0.40%+$1.34M
MBX Biosciences, Inc.(MBX)050,000+50,000$0$1.30M0.39%+$1.30M
Cytokinetics, Incorporated(CYTK)014,464+14,464$0$763.7K0.23%+$763.7K
Revolution Medicines, Inc.(RVMD)016,654+16,654$0$755.3K0.23%+$755.3K
Astria Therapeutics Inc056,287+56,287$0$618.9K0.19%+$618.9K
Edgewise Therapeutics, Inc.(EWTX)271,05719,900-251,157$4.88M$531.1K0.16%-$4.35M
Black Diamond Therapeutics I674,1980-674,198$3.14M$0—-$3.14M
Celldex Therapeutics, Inc.(CLDX)144,4670-144,467$5.35M$0—-$5.35M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)101,4790-101,479$4.59M$0—-$4.59M
Fulcrum Therapeutics, Inc.(FULC)696,4640-696,464$4.32M$0—-$4.32M
GSK plcADR(GSK)245,9330-245,933$9.47M$0—-$9.47M
Immunocore Holdings plcADS(IMCR)339,3510-339,351$11.50M$0—-$11.50M
Insmed Incorporated(INSM)86,9800-86,980$5.83M$0—-$5.83M
Jasper Therapeutics, Inc.(JSPR)143,7750-143,775$3.26M$0—-$3.26M
Kalvista Pharmaceuticals Inc736,7650-736,765$8.68M$0—-$8.68M
Larimar Therapeutics, Inc.(LRMR)704,3490-704,349$5.11M$0—-$5.11M
Merck & Co., Inc.(MRK)81,5080-81,508$10.15M$0—-$10.15M
Silence Therapeutics plcADS(SLN)124,8660-124,866$2.37M$0—-$2.37M
Spyre Therapeutics, Inc.(SYRE)150,4500-150,450$3.54M$0—-$3.54M
Page 1 of 1
STEMPOINT CAPITAL LP — 13F Holdings — Q3 2024 | TickerTrail